BR8108820A - Processo e sonda de diagnostico - Google Patents

Processo e sonda de diagnostico

Info

Publication number
BR8108820A
BR8108820A BR8108820A BR8108820A BR8108820A BR 8108820 A BR8108820 A BR 8108820A BR 8108820 A BR8108820 A BR 8108820A BR 8108820 A BR8108820 A BR 8108820A BR 8108820 A BR8108820 A BR 8108820A
Authority
BR
Brazil
Prior art keywords
probe
diagnostic process
diagnostic
Prior art date
Application number
BR8108820A
Other languages
English (en)
Inventor
Henry Anthony Erlich
Michael Alan Lovett
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of BR8108820A publication Critical patent/BR8108820A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
BR8108820A 1980-09-24 1981-09-22 Processo e sonda de diagnostico BR8108820A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19036180A 1980-09-24 1980-09-24
US29796281A 1981-09-02 1981-09-02
PCT/US1981/001272 WO1982001011A1 (en) 1980-09-24 1981-09-22 Diagnostic method and probe

Publications (1)

Publication Number Publication Date
BR8108820A true BR8108820A (pt) 1982-08-24

Family

ID=26886027

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8108820A BR8108820A (pt) 1980-09-24 1981-09-22 Processo e sonda de diagnostico

Country Status (10)

Country Link
EP (1) EP0050424B1 (pt)
JP (1) JPS57501692A (pt)
BR (1) BR8108820A (pt)
CA (1) CA1167376A (pt)
DE (1) DE3172347D1 (pt)
DK (1) DK232882A (pt)
ES (1) ES505713A0 (pt)
IL (1) IL63907A0 (pt)
NO (1) NO821569L (pt)
WO (1) WO1982001011A1 (pt)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI76888C (fi) * 1981-04-29 1988-12-12 Ciba Geigy Ag Nya medel och foerpackningar foer immunologiska analyser.
FI69639C (fi) * 1982-07-02 1986-03-10 Orion Yhtymae Oy Preparat foer anvaendning vid klamydia-diagnostik
US4863729A (en) * 1984-06-20 1989-09-05 Linus Pauling Institute Of Science And Medicine Method for preparing a macromolecular monoclonal antibody composition
US4647544A (en) * 1984-06-25 1987-03-03 Nicoli David F Immunoassay using optical interference detection
DE3722273A1 (de) * 1986-07-08 1988-01-21 Bio Rad Laboratories Festphasen-bindungsreagentien, ihre herstellung und sie enthaltende assay-kits
NZ221895A (en) * 1986-09-26 1990-09-26 Univ California Composition and method for the diagnosis of pseudomonas aeruginosa infections
US6277592B1 (en) 1996-07-31 2001-08-21 Purina Mills, Inc. Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof
US6297027B1 (en) 1996-07-31 2001-10-02 Purina Mills, Inc. Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6103468A (en) * 1997-10-07 2000-08-15 Labatt Brewing Company Limited Rapid two-stage polymerase chain reaction method for detection of lactic acid bacteria in beer
WO2000079009A2 (en) 1999-06-22 2000-12-28 Invitrogen Corporation Improved primers and methods for the detection and discrimination of nucleic acids
US6830902B1 (en) 1999-07-02 2004-12-14 Invitrogen Corporation Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
US6692918B2 (en) 1999-09-13 2004-02-17 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
CN102586228A (zh) 1999-09-13 2012-07-18 纽亘技术公司 用于多核苷酸序列线性等温扩增的方法及组合物
WO2001044457A2 (en) 1999-12-16 2001-06-21 Monsanto Technology Llc Dna constructs for expression of heterologous polypeptides in plants
AU2001271595A1 (en) 2000-06-26 2002-01-08 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
US7846733B2 (en) 2000-06-26 2010-12-07 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
EP1366191A2 (en) 2000-12-11 2003-12-03 Alexion Pharmaceuticals, Inc. Nested oligonucleotides containing hairpin for nucleic acid amplification
JP2005503755A (ja) 2000-12-13 2005-02-10 ニューゲン テクノロジーズ， インコーポレイテッド 核酸配列の複数コピーを作製するための方法および組成物、ならびにそれらを検出する方法
US6794141B2 (en) 2000-12-22 2004-09-21 Arcturus Bioscience, Inc. Nucleic acid amplification
US6635451B2 (en) 2001-01-25 2003-10-21 Abbott Laboratories Desaturase genes and uses thereof
CA2416963C (en) 2001-03-09 2012-01-10 Nugen Technologies, Inc. Methods and compositions for amplification of rna sequences
AU2002308633A1 (en) 2001-05-09 2002-11-18 Monsanto Technology Llc Metabolite transporters
EP1950305A1 (en) 2001-05-09 2008-07-30 Monsanto Technology, LLC Tyr a genes and uses thereof
US7291477B2 (en) 2001-07-03 2007-11-06 Xenotope Diagnostics, Inc. Method and device for trichomonas detection
WO2003025202A2 (en) 2001-09-19 2003-03-27 Alexion Pharmaceuticals, Inc. Engineered templates and their use in single primer amplification
US7414111B2 (en) 2001-09-19 2008-08-19 Alexion Pharmaceuticals, Inc. Engineered templates and their use in single primer amplification
US20030165859A1 (en) 2001-10-23 2003-09-04 Invitrogen Corporation Primers and methods for the detection and discrimination of nucleic acids
US7211656B2 (en) 2002-01-30 2007-05-01 Abbott Laboratories Desaturase genes, enzymes encoded thereby, and uses thereof
AU2003237834A1 (en) 2002-05-15 2003-12-02 Monsanto Technology Llc Method of increasing plant organ and seed size in a plant
AU2003240795A1 (en) 2002-05-24 2003-12-12 Invitrogen Corporation Nested pcr employing degradable primers
CA2495051C (en) 2002-08-05 2012-04-24 Quanta Biosciences Improved compositions for in vitro amplification of nucleic acids
US7498408B2 (en) 2002-09-23 2009-03-03 E. I. Du Pont De Nemours And Company Ryanodine receptor polypeptides
US7094879B2 (en) 2002-10-02 2006-08-22 Abbott Laboratories Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
WO2004092418A2 (en) 2003-04-14 2004-10-28 Nugen Technologies, Inc. Global amplification using a randomly primed composite primer
WO2005060664A2 (en) 2003-12-10 2005-07-07 Monsanto Technology Llc Stress tolerant plants and methods thereof
BRPI0511236A (pt) 2004-06-04 2007-11-27 Fluxome Sciences As método para a produção de ácidos graxos poliinsaturados com quatro ou mais ligações duplas, saccharomyces cerevisiae geneticamente modificado que tem capacidade de produzir ácidos graxos poliinsaturados com quatro ou mais ligações duplas quando desenvolvido em um substrato que não de ácido graxo, composição, uso da composição e uso de um saccharomyces cervisiae geneticamente modificado
US7456270B2 (en) 2004-09-01 2008-11-25 Abbott Laboratories Δ6-desaturase genes and uses thereof
CN104644627A (zh) 2004-09-14 2015-05-27 科罗拉多大学董事会 基于基因靶向使用布新洛尔的治疗方法
US7790363B2 (en) 2005-02-07 2010-09-07 Abbott Laboratories Inc. Diagnostic test for vitamin B12
US8624027B2 (en) 2005-05-12 2014-01-07 Abbvie Inc. Combination therapy for treating cancer and diagnostic assays for use therein
US8017103B2 (en) 2005-07-01 2011-09-13 Board Of Regents, The University Of Texas System Methods and compositions to diagnose trichomonas infection
CN101356285A (zh) 2005-08-16 2009-01-28 梅洛根有限责任公司 鉴定陨石色基因的方法
EP1929046B1 (en) 2005-09-07 2012-07-11 Nugen Technologies, Inc. Improved nucleic acid amplification procedure
US7439028B2 (en) 2005-09-30 2008-10-21 Board Of Regents, The University Of Texas System Methods and compositions to correlate Trichomonas infection with prostate cancer
DK1954718T3 (en) 2005-11-30 2014-12-15 Abbvie Inc Anti-A-globulomer antibodies antigenbindingsgrupper thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods for producing said antibodies,
EP1976877B2 (en) 2005-11-30 2016-10-05 AbbVie Inc. Monoclonal antibodies against amyloid beta protein and uses thereof
US7803567B2 (en) 2005-12-09 2010-09-28 Board Of Regents, The University Of Texas System Methods and compositions for detecting trichomonas in a sample contacted with fixative
US7285388B1 (en) 2006-04-07 2007-10-23 Merlogen, Llc Methods for identification of alport syndrome
US8933209B2 (en) 2006-04-26 2015-01-13 Abbvie Inc. Dep2 and its uses in major depressive disorder and other related disorders
CA2909340C (en) 2006-05-25 2019-07-02 Monsanto Technology Llc A method to identify disease resistant quantitative trait loci in soybean and compositions thereof
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2486928A1 (en) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
AR071243A1 (es) 2007-08-29 2010-06-09 Monsanto Technology Llc Metodos y composiciones para usar plantas haploides en el mapeo genetico de caracteristicas, como resistencia a enfermedades
US8034568B2 (en) 2008-02-12 2011-10-11 Nugen Technologies, Inc. Isothermal nucleic acid amplification methods and compositions
US8030471B2 (en) 2008-03-06 2011-10-04 Abbott Laboratories Plasmodium malariae and Plasmodium ovale genes and uses thereof
US8268981B2 (en) 2008-03-06 2012-09-18 Abbott Laboratories Plasmodium malariae and plasmodium ovale genes and uses thereof
WO2009117698A2 (en) 2008-03-21 2009-09-24 Nugen Technologies, Inc. Methods of rna amplification in the presence of dna
BRPI0911551B8 (pt) 2008-04-24 2023-10-03 Monsanto Technology Llc Método para produzir planta de soja resistente a ferrugem asiática da soja (asr)
CN102239254B (zh) 2008-10-06 2014-02-26 雅培制药有限公司 △-8去饱和酶基因、由其编码的酶及其用途
US8288124B2 (en) 2008-11-20 2012-10-16 Abbott Laboratories Cloning, expression and purification of recombinant porcine intrinsic factor for use in diagnostic assay
EP2370568B1 (en) 2008-12-10 2017-07-19 Dana-Farber Cancer Institute, Inc. Mek mutations conferring resistance to mek inhibitors
JP5616905B2 (ja) 2009-01-31 2014-10-29 アッヴィ・インコーポレイテッド オーロラキナーゼｂ阻害剤治療に対する応答性を予見およびモニターするためのマーカー
CA2751293A1 (en) 2009-02-11 2010-08-19 Abbott Laboratories Methods and compositions for identifying, classifying and monitoring subject having bcl-2 family inhibitor-resistant tumors and cancers
US8063193B2 (en) 2009-03-27 2011-11-22 Abbott Laboratories Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
WO2010132817A1 (en) 2009-05-14 2010-11-18 Cancer Prevention Pharmaceuticals, Llc Carcinoma diagnosis and treatments, based on odc1 genotype
EP2449381A1 (en) 2009-06-30 2012-05-09 Abbott Laboratories Markers of xmrv infection and uses thereof
US8188335B2 (en) 2009-07-17 2012-05-29 Abbott Laboratories Δ9-elongase for production of polyunsaturated fatty acid-enriched oils
WO2011032088A1 (en) 2009-09-11 2011-03-17 Arca Biopharma, Inc. Polymorphisms in the pde3a gene
DK2515899T3 (en) 2009-12-23 2016-08-15 Arca Biopharma Inc METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASES AND CONDITIONS
JP5933459B2 (ja) 2010-02-25 2016-06-08 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Ｂｒａｆ阻害剤に対する耐性を付与するｂｒａｆ突然変異
EA030276B1 (ru) 2010-03-09 2018-07-31 Дана-Фарбер Кэнсер Инститьют, Инк. Способы идентификации страдающих раком пациентов и лечения рака у пациентов, у которых имеется или развивается резистентность к первой терапии рака
CA2796339C (en) 2010-04-15 2020-03-31 Abbott Laboratories Amyloid-beta binding proteins
US20130217743A1 (en) 2010-05-14 2013-08-22 Cancer Prevention Pharmaceuticals, Inc. Cancer prevention and treatment methods based on dietary polyamine content
ES2873933T3 (es) 2010-06-09 2021-11-04 Dana Farber Cancer Inst Inc Una mutación de MEK1 que confiere resistencia a inhibidores de RAF y de MEK
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
WO2012024518A1 (en) 2010-08-18 2012-02-23 Abbott Laboratories Molecular detection of xmrv infection
WO2012024513A2 (en) 2010-08-18 2012-02-23 Abbott Laboratories Molecular detection of xmrv infection
WO2012149193A2 (en) 2011-04-29 2012-11-01 Monsanto Technology Llc Diagnostic molecular markers for seed lot purity traits in soybeans
EP2750495B1 (en) 2011-08-31 2019-02-27 Seminis Vegetable Seeds, Inc. Methods and compositions for watermelon firmness
US10314253B2 (en) 2012-12-04 2019-06-11 Seminis Vegetable Seeds, Inc. Methods and compositions for watermelon sex expression
US10294489B2 (en) 2013-03-15 2019-05-21 Board Of Trustees Of Southern Illinois University Soybean resistant to cyst nematodes
US10059999B2 (en) 2013-06-10 2018-08-28 Monsanto Technology Llc Molecular markers associated with soybean tolerance to low iron growth conditions
NZ791803A (en) 2013-11-27 2023-02-24 Seminis Vegetable Seeds Inc Disease resistance loci in onion
ES2927871T3 (es) 2014-02-21 2022-11-11 Syngenta Participations Ag Loci genéticos asociados con una mayor fertilidad en el maíz
NZ630710A (en) 2014-02-27 2016-03-31 Seminis Vegetable Seeds Inc Compositions and methods for peronospora resistance in spinach
US10316369B2 (en) 2014-06-27 2019-06-11 Seminis Vegetable Seeds, Inc. Methods and assays for male sterile watermelon
EP3005862A1 (en) 2014-10-10 2016-04-13 Seminis Vegetable Seeds, Inc. Melon plants with improved disease tolerance
US10448595B2 (en) 2015-09-03 2019-10-22 Seminis Vegetable Seeds, Inc. Downy mildew resistant lettuce plants
EP3199642A1 (en) 2016-02-01 2017-08-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Plant breeding using high throughput sequencing
CN109195603B (zh) 2016-03-24 2022-11-08 科瑞华生物技术有限公司 用tg02治疗癌症
US10633386B2 (en) 2016-04-12 2020-04-28 The Regents Of The University Of Michigan BET protein degraders
ES2857743T3 (es) 2016-09-13 2021-09-29 Univ Michigan Regents 1,4-diazepinas fusionadas como degradadores de proteína BET
AU2017326171B2 (en) 2016-09-13 2021-12-09 The Regents Of The University Of Michigan Fused 1,4-oxazepines as BET protein degraders
AU2017232187B2 (en) 2016-09-30 2023-11-09 Seminis Vegetable Seeds, Inc. Xanthomonas resistant brassica oleracea plants
US11952572B2 (en) 2017-08-14 2024-04-09 Epizyme, Inc. Methods of treating cancer by inhibiting SETD2
TWI785098B (zh) 2017-08-18 2022-12-01 開曼群島商科賽睿生命科學公司 Tg02之多晶型
US11267822B2 (en) 2017-09-13 2022-03-08 The Regents Of The University Of Michigan BET bromodomain protein degraders with cleavable linkers
CN112912143A (zh) 2018-10-08 2021-06-04 美国密歇根州立大学试剂中心 小分子mdm2蛋白降解剂
CA3145881A1 (en) 2019-01-15 2020-07-23 Seminis Vegetable Seeds, Inc. Green bean plants with improved resistance to sclerotinia sclerotiorum and genetic markers therefor
EP3983084A1 (en) 2019-06-12 2022-04-20 Vanderbilt University Amino acid transport inhibitors and the uses thereof
CN114269715A (zh) 2019-06-12 2022-04-01 范德比尔特大学 作为氨基酸转运抑制剂的二苄基胺
US11542513B2 (en) 2019-09-26 2023-01-03 Seminis Vegetable Seeds, Inc. Lettuce plants having resistance to Nasonovia ribisnigri biotype Nr:1
AU2021204717A1 (en) 2020-07-15 2022-02-03 Seminis Vegetable Seeds, Inc. Green Bean Plants with Improved Disease Resistance
US20230193310A1 (en) 2021-12-10 2023-06-22 Seminis Vegetabe Seeds, Inc. Lettuce plants having resistance to downy mildew
WO2023250288A2 (en) 2022-06-21 2023-12-28 Seminis Vegetable Seeds, Inc. Novel qtls conferring resistance to cucumber mosaic virus

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941876A (en) * 1973-04-25 1976-03-02 Gte New Ventures Corporation In vitro method for determining allergic hypersensitivity
FR2233024A1 (en) * 1973-06-15 1975-01-10 Greyward Lab Interconti Treponema haemagglutination test - using tanned avian erythrocytes as carrier for ireponema antigen
US3979509A (en) * 1974-09-03 1976-09-07 General Electric Company Opaque layer method for detecting biological particles
US3952091A (en) * 1974-10-23 1976-04-20 Hoffmann-La Roche Inc. Simultaneous multiple radioimmunoassay
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4094759A (en) * 1975-01-03 1978-06-13 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method for simultaneous quantitative analysis of several constituents in a sample
US4097149A (en) * 1975-02-03 1978-06-27 Aladjem Frederick J Quantitative protein analysis by immunodiffusion
FR2353856A1 (fr) * 1976-06-02 1977-12-30 Chateau Guy Ruban destine a servir de support a une reaction par exemple chimique ou biochimique, et procede d'analyse le mettant en oeuvre
US4294817A (en) * 1977-11-25 1981-10-13 International Diagnostic Technology, Inc. Method of fluoro immunoassay
DK138080A (da) * 1979-04-02 1980-10-03 Research Corp Fremgangsmaade til serologisk undersoegelse af kilder som mistaenkes for at indeholde antistoffer mod chlamydia trachomatis

Also Published As

Publication number Publication date
CA1167376A (en) 1984-05-15
JPS57501692A (pt) 1982-09-16
ES8303072A1 (es) 1983-02-01
EP0050424A1 (en) 1982-04-28
DK232882A (da) 1982-05-24
IL63907A0 (en) 1981-12-31
WO1982001011A1 (en) 1982-04-01
ES505713A0 (es) 1983-02-01
DE3172347D1 (en) 1985-10-24
EP0050424B1 (en) 1985-09-18
NO821569L (no) 1982-05-12

Similar Documents

Publication Publication Date Title
BR8108820A (pt) Processo e sonda de diagnostico
BR8108113A (pt) Dispositivo de analise e processo de aplicacao do mesmo
BR8101370A (pt) Sonda esofageana
BR8009056A (pt) Processo e aperelho de misturador
BR8101154A (pt) Instrumento de grampeamento cirurgico e bigorna
AR229779A1 (es) Conjunto de sonda
BR7705256A (pt) Processo e preparacao de eteno
IT1096588B (it) Processo per la preparazione di aralchilfenoleteri e di alchilfenoleteri
BR8100214A (pt) Sonda rotativa e processo de furacao
IT1092192B (it) Aparecchio e procedimento di filatura diretta
BR8007386A (pt) Processo e aparelho de amarracao de artigos
DK408080A (da) Testilbehandlingsmiddel
BR7905539A (pt) Processo de ensaio de pocos
BR8101187A (pt) Envoltorio de sonda para aparelho de diagrafia e processo de sua fabricacao
BR8102968A (pt) Processo de sintese de cloroformiatos - clorados e cloroformiatos - clorados
BR8104565A (pt) Catalisador e processo de preparacao de catalisador
AR224758A1 (es) Metodo y aparato de perfilado de pozos
BR7802606A (pt) Processo e aparelho de criodessecamento por hiperfrequencia
FI811603L (fi) Ionspecifikt diagnostiskt foerfarande och anordning
DD230151A3 (de) Kryochirurgisches instrument
IT1193576B (it) 17alfa-acilossi-5beta-corticoidi e 17alfa-acilossi-5alfa-corticoidi
BR7801587A (pt) Processo para enriquecimento e separacao de tritio e/ou hidreto de tritio de agua de tritio
BR8101369A (pt) Sonda esofageana
IT1142142B (it) 5alfa-androstan-17beta-carbossilati e 5beta-androstan-17beta-carbossilati
IT1099505B (it) A-aminometilen-b-formilaminopropionitrile e processo per la sua preparazione